ChemLifeIntel
Access
ChemLifeIntel/Companies/Biocompatibles UK, Ltd.

Biocompatibles UK, Ltd.

HIGH RISKHQ: — · Private · Founded —
LISTINGPrivateFOUNDED0
FOCUS THERAPY AREAS
Manufacturer
COMPANY INTELLIGENCE SNAPSHOTlive
0
Manufacturing Sites
1
Intelligence Briefs
0
Active Regulatory Actions
HQ Country
NO ACTIVE REGULATORY ACTIONSClean compliance footprint across 0 monitored sites · HQ
View regulatory detail

INTELLIGENCE

Showing 1 of 1 briefs on Biocompatibles UK, Ltd.
REGULATORY INTELLIGENCE·Recall

Biocompatibles UK's Varithena Recall Highlights Critical Packaging Quality Control for Injectable Foam

Biocompatibles UK, Ltd. initiated a Class III recall (D-0113-2025) for 432 units of its Varithena (polidocanol injectable foam) Administration Packs distributed nationwide in the USA. The issue involved incorrect silicone oil-free NormJect 10 mL Luer Lock Solo syringes being packaged instead of Luer Solo syringes. This recall, initiated August 15, 2024, and terminated February 21, 2025, underscores the critical need for stringent quality control in medical device component packaging.

90-Day Activity
Biocompatibles UK,Varithena (polidocanol injectable foam) Administration Pack
CMCatherine Morrow· Senior Regulatory Intelligence Analyst
2024-12-18